Not sure I understand your quesiton, but one thing I have done in the spread sheet is for companies that have multiple revenue streams such as Hoffman LaRoche, for example, where they sell diagnostic equipment AND pharmaceuticals, I used only the diagnostic equipment number in their revenues. In a couple of other instances, I used similar "editiing" of the numbers.

For the most part, when a license was signed, I'd go to the latest SEC filing if there was one, for that company, and take the annual revenue number from there. If they don't file with the SEC, I went to their website to find info. If none there, I went to some other publication that referneced annual revenues for the company. That's the extent of the accuracy that I've sought to acheive.

Whether Alliacense "weights" the licensing fees, I have no idea except to assume that when they say they have the ability to reverse engineer and prove infringement of products, and when they say licensing is based on the amount of infringing product, they have a way of measuring that that is independent of the revenue numbers I'm using. Maybe once the patents finish the USPTO process and TPL/PTSC WIN a court battle IN THE COURT, perhaps then we'll have some better info....and then again, perhaps not, lol.